Biomarkers for colorectal cancer detection: An insight into colorectal cancer and FDA-approved biomarkers

Mohammad Yasin Zamanian ^1,2 * , Darmadi Darmadi ³, Razieh Darabi ⁴, Raed Fanoukh Aboqader Al-Aouadi ⁵, Mehraveh Sadeghi Ivraghi ⁶, Esra Küpeli Akkol ⁷ *

Cited by CrossRef: 2

1- Lobo-Castañón M, Díaz-Fernández A. Aptamer-Based Strategies for Colorectal Cancer Detection: Emerging Technologies and Future Directions. Biosensors. 2025;15(11):726 [Crossref]

2- Pricope D, Grigoraș A, Dimofte G, Amalinei C. The Multifaceted Role of Annexin A1 in Colorectal Cancer: From Molecular Mechanisms to Predictive and Prognostic Implications. Medical Sciences. 2025;13(4):263 [Crossref]

3- Kokoropoulos P, Christodoulou S, Tsiakanikas P, Poulios E, Vassiliu P, Kontos C, Arkadopoulos N. A Retrospective Study in Colorectal Adenocarcinoma Uncovers the Potential of Circ-CCT3 as a Predictor of Tumor Recurrence. Biomedicines. 2025;13(10):2432 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2024): 20%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of
Follower of ICMJE
Permission: Creative Commons